Organogenesis Holdings (ORGO) Current Assets (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Current Assets of $268.5 million for Q1 2026, little changed year-over-year from $268.2 million in Q1 2025, and down 25.87% quarter-over-quarter from $362.2 million in Q4 2025.
Organogenesis Holdings (ORGO) Current Assets (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Current Assets history runs 12 years deep, the most recent figure standing at $268.5 million for Q1 2026.
- In Q1 2026, Current Assets changed 0.13% year-over-year to $268.5 million; the TTM figure through Mar 2026 stood at $268.5 million (changed 0.13% YoY), while the FY2025 annual figure was $362.2 million, up 26.67% from the prior year.
- Current Assets for Q1 2026 stood at $268.5 million, down from $362.2 million in the prior quarter.
- The five-year high for Current Assets was $362.2 million in Q4 2025, with the low at $216.4 million in Q2 2023.
- The 5-year median for Current Assets is $231.5 million (2022), against an average of $248.9 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets dropped 6.52% in 2023, then climbed 27.06% in 2024.
- Organogenesis Holdings' Current Assets stood at $222.6 million in 2022, then increased by 1.09% to $225.0 million in 2023, then gained by 27.06% to $285.9 million in 2024, then rose by 26.67% to $362.2 million in 2025, then fell by 25.87% to $268.5 million in 2026.
- Business Quant data shows ORGO's Current Assets at $268.5 million in Q1 2026, $362.2 million in Q4 2025, and $299.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 200.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 200.30 Mn |
| Mar 31, 2026 | 268.50 Mn |
| Dec 31, 2025 | 362.19 Mn |
| Sep 30, 2025 | 299.75 Mn |
| Jun 30, 2025 | 260.22 Mn |
| Mar 31, 2025 | 268.16 Mn |
| Dec 31, 2024 | 285.94 Mn |
| Sep 30, 2024 | 238.51 Mn |
| Jun 30, 2024 | 234.19 Mn |
| Mar 31, 2024 | 227.17 Mn |
| Dec 31, 2023 | 225.04 Mn |
| Sep 30, 2023 | 225.57 Mn |
| Jun 30, 2023 | 216.44 Mn |
| Mar 31, 2023 | 216.82 Mn |
| Dec 31, 2022 | 222.61 Mn |
| Sep 30, 2022 | 230.53 Mn |
| Jun 30, 2022 | 231.54 Mn |
| Mar 31, 2022 | 217.85 Mn |
| Dec 31, 2021 | 226.98 Mn |
| Sep 30, 2021 | 211.84 Mn |